Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Escherichia coli
ribonuclease III
, purified to homogeneity from an overexpressing bacterial strain, exhibits a high catalytic efficiency and thermostable processing activity in vitro. The
RNase III
-catalyzed cleavage of a 47 nucleotide substrate (R1.1 RNA), based on the bacteriophage T7 R1.1 processing signal, follows substrate saturation kinetics, with a Km of 0.26 microM, and kcat of 7.7 min.-1 (37 degrees C, in buffer containing 250 mM potassium glutamate and 10 mM MgCl2). Mn2+ and
Co2+
can support the enzymatic cleavage of the R1.1 RNA canonical site, and both metal ions exhibit concentration dependences similar to that of Mg2+. Mn2+ and
Co2+
in addition promote enzymatic cleavage of a secondary site in R1.1 RNA, which is proposed to result from the altered hydrolytic activity of the metalloenzyme (
RNase III
'star' activity), exhibiting a broadened cleavage specificity. Neither Ca2+ nor Zn2+ support
RNase III
processing, and Zn2+ moreover inhibits the Mg(2+)-dependent enzymatic reaction without blocking substrate binding.
RNase III
does not require monovalent salt for processing activity; however, the in vitro reactivity pattern is influenced by the monovalent salt concentration, as well as type of anion. First, R1.1 RNA secondary site cleavage increases as the salt concentration is lowered, perhaps reflecting enhanced enzyme binding to substrate. Second, the substitution of glutamate anion for chloride anion extends the salt concentration range within which efficient processing occurs. Third, fluoride anion inhibits
RNase III
-catalyzed cleavage, by a mechanism which does not involve inhibition of substrate binding.
...
PMID:Ribonuclease III cleavage of a bacteriophage T7 processing signal. Divalent cation specificity, and specific anion effects. 849 5
In Escherichia coli, the corA gene encodes a transporter that mediates the influx of Co(2+), Mg(2+), and Ni(2+) into the cell. During the course of experiments aimed at identifying
RNase III
-dependent genes in E. coli, we observed that steady-state levels of corA mRNA as well as the degree of
cobalt
influx into the cell were dependent on cellular concentrations of
RNase III
. In addition, changes in corA expression levels by different cellular concentrations of
RNase III
were closely correlated with degrees of resistance of E. coli cells to Co(2+) and Ni(2+). In vitro and in vivo cleavage analyses of corA mRNA identified
RNase III
cleavage sites in the 5'-untranslated region of the corA mRNA. The introduction of nucleotide substitutions at the identified
RNase III
cleavage sites abolished
RNase III
cleavage activity on corA mRNA and resulted in prolonged half-lives of the mRNA, which demonstrates that
RNase III
cleavage constitutes a rate-determining step for corA mRNA degradation. These findings reveal an
RNase III
-mediated regulatory pathway that functions to modulate corA expression and, in turn, the influx of metal ions transported by CorA in E. coli.
...
PMID:RNase III controls the degradation of corA mRNA in Escherichia coli. 2234 2